Chr. Hansen and Glycom settle HMO patent disputes inherited from Jennewein acquisition

Related Articles

FormattedPicture

NUTRITION & HEALTH NEWS

Research published in the Journal of Cell Host & Microbe is furthering interest in human breast milk and its therapeutic applications for the gut microbiome. Opening... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

During an “uncertain macroeconomic environment” Chr. Hansen reports a 17% organic growth to date from the start of the year for the health and nutrition... Read More

FormattedPicture

FOOD INGREDIENTS NEWS

Ripples of innovation across the lactosphere are being generated by new food technology advancements, which include a new superfood sourced from discarded bovine... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

Food Standards Australia New Zealand (FSANZ) has approved Chr. Hansen’s 2’-FL human milk oligosaccharide (HMO) for infant formula, paving the way for the... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

Nutrition giant Chr. Hansen is launching adjunct fermentation cultures alongside soy- and dairy-free cream cheese made from fava beans. The cream cheese, which has a... Read More

trans